Oklahoma 2024 Regular Session

Oklahoma House Bill HB3034 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
1	1
2	2
3		-	SENATE FLOOR VERSION - HB3034 SFLR Page 1
4		-	(Bold face denotes Committee Amendments) 1
	3	+	ENGR. H. B. NO. 3034 Page 1 1
5	4		2
6	5		3
7	6		4
8	7		5
9	8		6
10	9		7
11	10		8
12	11		9
13	12		10
14	13		11
15	14		12
16	15		13
17	16		14
18	17		15
19	18		16
20	19		17
21	20		18
22	21		19
23	22		20
24	23		21
25	24		22
26	25		23
27	26		24
28	27
29		-	SENATE FLOOR VERSION
30		-	March 28, 2024
31		-
32		-
33	28		ENGROSSED HOUSE
34	29		BILL NO. 3034 By: Stinson of the House
35	30
36	31		and
37	32
38	33		Pugh of the Senate
	34	+
	35	+
39	36
40	37
41	38
42	39
43	40		An Act relating to schools; creating the Emerson Kate
44	41		Cole Act; amending 70 O.S. 2021, Section 1-116.3,
45	42		which relates to school medication policies;
46	43		requiring school to call 911 if Epinephrine is
47	44		administered to a student; mandating school to notify
48	45		parent if student experiences possible allergic
49	46		reaction; requiring annual training for certain
50	47		teachers and school employees; prescribing content
51	48		and method for training; providing for
52	49		noncodification; providing an effective date ; and
53	50		declaring an emergency.
54	51
55	52
56	53
57	54
58	55
59	56		BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
60	57		SECTION 1. NEW LAW A new section of law not to b e
61	58		codified in the Oklahoma Statutes reads as follows:
62	59		This act shall be known and may be cited as the "Emerson Kate
63	60		Cole Act".
64	61		SECTION 2. AMENDATORY 70 O.S. 2021, Section 1-116.3, is
65	62		amended to read as follows:
66	63		Section 1-116.3 A. Notwithstanding the provisions of Section
67	64		1-116.2 of this title, the board of education of each school
	65	+	district shall adopt a pol icy on or before September 1, 2008, that
68	66
69		-	SENATE FLOOR VERSION - HB3034 SFLR Page 2
70		-	(Bold face denotes Committee Amendments) 1
	67	+	ENGR. H. B. NO. 3034 Page 2 1
71	68		2
72	69		3
73	70		4
74	71		5
75	72		6
76	73		7
77	74		8
78	75		9
79	76		10
80	77		11
81	78		12
82	79		13
83	80		14
84	81		15
85	82		16
86	83		17
87	84		18
88	85		19
89	86		20
90	87		21
91	88		22
92	89		23
93	90		24
94	91
95		-	district shall adopt a policy on or before September 1, 2008, that
96	92		permits the self-administration of inhaled asthma medication by a
97	93		student for treatment of asthma, the self-administration of
98	94		anaphylaxis medication by a student for treatment of anaphylaxis ,
99	95		and the self-administration of replacement pancreatic enzymes by a
100	96		student for treatment of cystic fibrosis. The policy shall require:
101	97		1. The parent or guardian of the student to authorize in
102	98		writing the student's self-administration of medication;
103	99		2. The parent or guardian of the student to provide to the
104	100		school a written statement from t he physician treating the student
105	101		that the student has asthm a, anaphylaxis, or cystic fibrosis and is
106	102		capable of, and has been instructed in the proper method of, self -
107	103		administration of medicat ion;
108	104		3. The parent or guardian of the student to provide to th e
109	105		school an emergency supply of the student 's medication to be
110	106		administered pursuant to the provisions of Section 1 -116.2 of this
111	107		title;
112	108		4. The school district to inform the parent or guardian of the
113	109		student, in writing, that the school district and its e mployees and
114	110		agents shall incur no liability as a result of any injury arising
115	111		from the self-administration of medication by the student; and
116	112		5. The parent or guardian of the student to sign a statement
117	113		acknowledging that the school district shall incur n o liability as a
	114	+	result of any injury arising from the self -administration of
	115	+	medication by the student.
118	116
119		-	SENATE FLOOR VERSION - HB3034 SFLR Page 3
120		-	(Bold face denotes Committee Amendments) 1
	117	+	ENGR. H. B. NO. 3034 Page 3 1
121	118		2
122	119		3
123	120		4
124	121		5
125	122		6
126	123		7
127	124		8
128	125		9
129	126		10
130	127		11
131	128		12
132	129		13
133	130		14
134	131		15
135	132		16
136	133		17
137	134		18
138	135		19
139	136		20
140	137		21
141	138		22
142	139		23
143	140		24
144	141
145		-	result of any injury arising from the self -administration of
146		-	medication by the student.
147	142		B. The school board of each school district that elects to
148	143		stock Epinephrine injectors or inhalers shall amend the policy
149	144		identified in subsection A of this section.
150	145		1. The amended policy for Epinephrine injec tors shall require:
151	146		a. the school district to inform the parent or guardian
152	147		of each student, in writing, that a school nurse or
153	148		school employee trained by a health care professional
154	149		or trained in correlation with the State Department of
155	150		Health's Diabetes Management Annual School Training
156	151		Program may administer, with parent or guardian
157	152		permission but without a health care provider order,
158	153		an Epinephrine injection to a student whom the school
159	154		nurse or trained school employee in good faith
160	155		believes is having an anaphylactic reaction,
161	156		b. a waiver of liability executed by a parent or guardian
162	157		be on file with the school district prior to the
163	158		administration of an Epinephrine injection pursuant to
164	159		paragraph 1 of this subsection, and
165	160		c. the school district to designat e the employee
166	161		responsible for obtaining the Epinephrine injectors at
167	162		each school site.
168	163		2. The amended policy for inhalers shall req uire:
	164	+	a. the school district to inform the parent or guardian
	165	+	of each student, in writing, that a school nurse or
169	166
170		-	SENATE FLOOR VERSION - HB3034 SFLR Page 4
171		-	(Bold face denotes Committee Amendments) 1
	167	+	ENGR. H. B. NO. 3034 Page 4 1
172	168		2
173	169		3
174	170		4
175	171		5
176	172		6
177	173		7
178	174		8
179	175		9
180	176		10
181	177		11
182	178		12
183	179		13
184	180		14
185	181		15
186	182		16
187	183		17
188	184		18
189	185		19
190	186		20
191	187		21
192	188		22
193	189		23
194	190		24
195	191
196		-	a. the school district to inform the parent or guardian
197		-	of each student, in writing, that a school nurse or
198	192		school employee trained by a health care professional
199	193		may administer an inhaler to a student whom the school
200	194		nurse or trained school employee in good faith
201	195		believes is having respiratory distress,
202	196		b. the school district to designate the employee
203	197		responsible for obtaining the inhalers and spacers or
204	198		holding chambers at each school site, and
205	199		c. the school district to notify the parent or guardian
206	200		of a student after administration of an inhaler.
207	201		C. The school district and its employees and agents shall incur
208	202		no liability as a result of any injury arising pursuant to the
209	203		discharge or nondischarge of the powers provided for pursuant to
210	204		subparagraph a of paragraphs 1 and 2 of subsection B of this
211	205		section.
212	206		D. A licensed physician who has prescriptive authority may
213	207		write a prescription for Epinephrine injectors and inhalers and
214	208		spacers or holding chambers to the school district in the name of
215	209		the district as a body corporate specified in Section 5 -105 of this
216	210		title which shall be maintained at each school site. Such physic ian
217	211		shall incur no liability as a result of any injury arising from the
218	212		use of the Epinephrine injectors or the inhalers and spacers or
219	213		holding chambers.
	214	+	E. The school district may maintain at ea ch school a minimum of
	215	+	two Epinephrine injectors and two inh alers with spacers or holding
220	216
221		-	SENATE FLOOR VERSION - HB3034 SFLR Page 5
222		-	(Bold face denotes Committee Amendments) 1
	217	+	ENGR. H. B. NO. 3034 Page 5 1
223	218		2
224	219		3
225	220		4
226	221		5
227	222		6
228	223		7
229	224		8
230	225		9
231	226		10
232	227		11
233	228		12
234	229		13
235	230		14
236	231		15
237	232		16
238	233		17
239	234		18
240	235		19
241	236		20
242	237		21
243	238		22
244	239		23
245	240		24
246	241
247		-	E. The school district may maintain at each school a minimum of
248		-	two Epinephrine injectors and two inh alers with spacers or holding
249	242		chambers in a secure location. Provided, however, that nothing in
250	243		this section shall be construed as c reating or imposing a duty on a
251	244		school district to maintain Epi nephrine injectors or inhalers with
252	245		spacers or holding chamb ers at a school site or sites.
253	246		F. In the event a student is believed to be having an
254	247		anaphylactic reaction or respiratory distress, a school employee
255	248		shall contact 911 as soon as possible. If Epinephrine is
256	249		administered to a student, a school employee sh all contact 911 as
257	250		soon as possible. The school district shall notify the parent or
258	251		guardian of any student who experiences a possible allergic reaction
259	252		as soon as possible.
260	253		G. The State Board o f Education, in consultation with the State
261	254		Board of Health, shall develop model policies which school districts
262	255		may use in compliance with this section. The model policies shall
263	256		include, at a minimum, required annual training for teachers and
264	257		school employees who are directly responsible for students on the
265	258		topics of food allergies, recognizing anaphylaxis, and instruction
266	259		on how to administer Epi nephrine. The training shall be completed
267	260		before the school year begins or upon hiring the teacher or school
268	261		employee. Documentation certifying completion of the requir ed
269	262		training shall be retained in the personnel file for the teacher or
270	263		school employee. The training may be provided online or in-person
	264	+	by the school nurse or a recognized food allergy and anaphylaxis
	265	+	training program.
271	266
272		-	SENATE FLOOR VERSION - HB3034 SFLR Page 6
273		-	(Bold face denotes Committee Amendments) 1
	267	+	ENGR. H. B. NO. 3034 Page 6 1
274	268		2
275	269		3
276	270		4
277	271		5
278	272		6
279	273		7
280	274		8
281	275		9
282	276		10
283	277		11
284	278		12
285	279		13
286	280		14
287	281		15
288	282		16
289	283		17
290	284		18
291	285		19
292	286		20
293	287		21
294	288		22
295	289		23
296	290		24
297	291
298		-	by the school nurse or a recognized food allergy and anaphylaxis
299		-	training program.
300	292		H. The State Board of E ducation, in consultation with the State
301	293		Board of Health, shall promulgate rules to implement this section.
302	294		I. As used in this section:
303	295		1. "Medication" means a metered dose inhaler or a dry powder
304	296		inhaler to alleviate asthmatic symptoms, prescribed by a physician
305	297		and having an individual label, an anaphylaxis medication used to
306	298		treat anaphylaxis including but not limited to Epinephrine injectors
307	299		prescribed by a physician and having an individual label, or
308	300		replacement pancreatic enzymes prescribed by a phy sician and having
309	301		an individual label; and
310	302		2. "Self-administration" means a student's use of medication
311	303		pursuant to prescription or written direction from a physician.
312	304		3. "Respiratory distress " means the perceived or actual
313	305		presence of coughing, wheezing or shortness of breath; and
314	306		4. "Inhaler" means a device that delivers a bronchodilator to
315	307		alleviate symptoms of respiratory distress that is manufactured in
316	308		the form of a metered -dose inhaler or dry-powder inhaler and that
317	309		may include a spacer or holding chamber that attaches to the inhaler
318	310		to improve the delivery of the bronchodilator.
319	311		J. The permission for self -administration of asthma,
320	312		anaphylaxis, or replacement pancreatic enzyme medication is
321	313		effective for the school year for which it is granted and shall be
	314	+	renewed each subsequent school year upon fulfillment of the
	315	+	requirements of this section.
322	316
323		-	SENATE FLOOR VERSION - HB3034 SFLR Page 7
324		-	(Bold face denotes Committee Amendments) 1
	317	+	ENGR. H. B. NO. 3034 Page 7 1
325	318		2
326	319		3
327	320		4
328	321		5
329	322		6
330	323		7
331	324		8
332	325		9
333	326		10
334	327		11
335	328		12
336	329		13
337	330		14
338	331		15
339	332		16
340	333		17
341	334		18
342	335		19
343	336		20
344	337		21
345	338		22
346	339		23
347	340		24
348	341
349		-	renewed each subsequent school year upon fulfillment of the
350		-	requirements of this section.
351	342		K. A student who is permitted to self -administer asthma,
352	343		anaphylaxis, or replacement pancreatic enzyme med ication pursuant to
353	344		this section shall be permitted to possess and use a prescribed
354	345		inhaler, anaphylaxis medication including but not limited to an
355	346		Epinephrine injector, or replacement pancreatic enzyme medication at
356	347		all times.
357	348		SECTION 3. This act shall become effective July 1, 2024.
358	349		SECTION 4. It being immediately necessary for the preservation
359	350		of the public peace, health or safety, an emergency is hereby
360	351		declared to exist, by reason whereof thi s act shall take effect and
361	352		be in full force from and after its passage and approval.
362		-	COMMITTEE REPORT BY: COMMITTEE ON HEALTH AND HUMAN SERVICES
363		-	March 28, 2024 - DO PASS
	353	+	Passed the House of R epresentatives the 26th day of February,
	354	+	2024.
	355	+
	356	+
	357	+
	358	+
	359	+	Presiding Officer of the House
	360	+	of Representatives
	361	+
	362	+
	363	+	Passed the Senate the ___ day of __________, 2024.
	364	+
	365	+
	366	+
	367	+
	368	+	Presiding Officer of the Senate
	369	+
	370	+